Select Page

The Infinium Global Research analyzes the Tissue Diagnostic Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global tissue diagnostic market. It will help a lot of decision-makers to develop strategies and find new opportunities in the global markets of tissue diagnostic.

The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the tissue diagnostic market during the period. The global tissue diagnostic market is expected to grow at a CAGR of 6.5% over the forecast period of 2017 – 2023.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

Tissue diagnosis market is likely to boost in upcoming years owing to the escalating demand for tissue diagnosis for the detection of cancer and other related problems. Tissue diagnosis involves an analysis of tissue part by removing it from the affected part by biopsy. Tissue analysis can be done by various techniques such as Immunohistochemistry (IHC) test, Fluorescent in situ hybridization (FISH), Silver in situ hybridization (SISH), and hematoxylin & eosin (H&E) to check the abnormal growth of the tissue. These specific tests helps to determine the type of drug therapy the patient will respond to.

Rising Number of Cancer Cases Globally is the Major Cause Driving the Tissue Diagnosis Market

The rising number of cancer cases globally is the major cause of driving the tissue diagnosis market. Cancerous cells form tumor inside the body which can be treated correctly with the proper diagnosis, different types of tissue diagnosis helps the doctor to know the reason of tumor formation and to plan effective treatment against cancer. According to WHO, 30%-50% of cancer problems can be prevented through better diagnosis and treatment.

Moreover, rising awareness about tissue diagnosis to treat the disease before its prevalence in the body has also boosted the market growth. However, low health literacy in low-income countries and stringent regulatory laws can hamper the growth of the market. On the other hand, increasing the need for betterment in cancer treatment can fuel the market in the near future.

Tissue Diagnosis Market: Segmentation

Tissue diagnostic market segmented on the basis of product type, application, disease, and end-user. Product type further sub-segmented into instruments and Consumables. Instrument segment further classified into Microscope, Non-contact Handheld IR Thermometer, Haemocytometer, NMR Tube, Others. While consumables segments classified into Reagent Kits and Others.

Application segmented further segmented into Hematoxylin and Eosin (H&E), immunohistochemistry (IHC), In Situ Hybridization. Disease segment bifurcated into lung cancer, lymphoma, pancreatic cancer, breast cancer, and others. The end-user segment further classified into hospitals, diagnostic laboratories, research organizations, contract research organizations, biotechnology companies.

The U.S. Drives the growth in the North America region as it is the Largest Market in the Region

Geographically, the global tissue diagnostic market segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The U.S. drives the growth in the North America region as it is the largest market in the region. The APAC region is anticipated to grow with a healthy rate in the forecast period. Asia-pacific region offers a substantial potential for market growth owing to rapid growth in markets such as India and China.

Tissue Diagnosis Market: Regional Analysis

Some of the major key players in the market are F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers, Danaher, bioMérieux SA, QIAGEN, Johnson & Johnson Services, Inc., Becton Dickinson & Company (BD), Merck KGaA, Thermo Fisher Scientific, Inc., and others.

Browse Detailed TOC and Description of this Exclusive Report@

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the tissue diagnostic.

=> Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2023.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.